Vitality Biopharma CEO says cannabinoids have potential for neurological/inflammatory conditions

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email



Vitality Biopharma (OTCQB:VBIO) CEO Robert Brooke tells Proactive Investors about the company’s development of cannabinoid prodrug pharmaceuticals and how cannabinoids can be used for the treatment of serious neurological and inflammatory disorders.

Brooke says the cannabinoid prodrugs (known as cannabosides) can, upon ingestion, enable selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. This could be used by people with conditions such as Crohn’s, IBS and colitis.

Brooke says cannabinoids also have the potential to be used as an alternative to opiate abuse.

View original source video by clicking here

On Key

Related Posts

The strains that made Cookies

When it comes to cannabis culture and products, few names ring off in the streets like Cookies. Its genetics have been used to create some

5 MIN WARM UP FOR AT HOME WORKOUTS (No Jumping)

Join me in this 5 min APARTMENT FRIENDLY (no jumping) warm up routine for at home workouts! Warming up is so important and you should be warming up before EVERY single workout! DOWNLOAD YOUR MADFIT APP FREE TRIAL HERE: https://madfit.app.link/e/store #WithMe #WarmUp #HomeWorkout THE MAT I USE (Exercise 6X4): http://gorillamats.com?aff=19 (MADFIT10 for 10% off) SUBSCRIBE…